anacin
Generic: asprin and caffeine
Labeler: insight pharmaceuticals llcDrug Facts
Product Profile
Brand Name
anacin
Generic Name
asprin and caffeine
Labeler
insight pharmaceuticals llc
Dosage Form
TABLET
Routes
Active Ingredients
aspirin 400 mg/1, caffeine 32 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63736-200
Product ID
63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2009-06-25
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63736200
Hyphenated Format
63736-200
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
anacin (source: ndc)
Generic Name
asprin and caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
- 32 mg/1
Packaging
- 1 BOTTLE in 1 BOX (63736-200-90) / 100 TABLET in 1 BOTTLE
- 1 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4895609d-1ec8-4ebd-8b6e-61ccd452ad5b", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["198479", "211292"], "spl_set_id": ["51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Insight Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOX (63736-200-90) / 100 TABLET in 1 BOTTLE", "package_ndc": "63736-200-90", "marketing_start_date": "20090625"}, {"sample": false, "description": "1 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE", "package_ndc": "63736-200-93", "marketing_start_date": "20090625"}], "brand_name": "Anacin", "product_id": "63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "63736-200", "generic_name": "Asprin and Caffeine", "labeler_name": "Insight Pharmaceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Anacin", "active_ingredients": [{"name": "ASPIRIN", "strength": "400 mg/1"}, {"name": "CAFFEINE", "strength": "32 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20090625", "listing_expiration_date": "20261231"}